Flagship · Bulletin

Macro rationale

Live macro digest holds NEUTRAL: extension fires (QQQ +12.23% vs 200d) keeping cash in the upper NEUTRAL band despite constructive VIX (-11.34% vs 200d) and tight HY OAS (2.75 < 2.90 SMA); RSIs 62-63 and a -8.37% book drawdown block a full risk-on call. This is an event-driven patch scope-locked to [MP,MU,NEM,TSM,NVDA,ASML,AVGO,ANET,FN,CCJ,GEV,SCCO]; all other names held at delta 0 per the trigger, and stale_policy=YES blocks any add/open regardless. The gate is MU's blowout fiscal Q3 (+17% rev / +22% op-income, $27B capex step-up, 16 Strategic Customer Agreements covering ~20% of DRAM & 1/3 NAND through 2030). Read: this is the cleanest confirmation yet that the AI-memory/hyperscaler-capex flow is structurally intact — it de-risks the compute pillar and is a reason to HOLD the compute franchises through their rate-driven score drift (NVDA -16, ASML -22, AVGO -16), not trim them. The only new negative flow signals are in energy: OPEC+'s fifth consecutive 188k bpd Aug supply hike with Hormuz recovering erodes the inflation-hedge premium, and MP's China MOFCOM No.23 blacklist pressures its magnet-ramp thesis. Energy sits at 34.55% (approaching the 40% cap) with GEV (8.93%, drift -12) and MP (6.14%) overextended via pure appreciation. I trim those two decisively.

Thesis

Event-driven patch, scope-locked to [MP,MU,NEM,TSM,NVDA,ASML,AVGO,ANET,FN,CCJ,GEV,SCCO]; all other names held at delta 0 per the trigger, and stale_policy=YES blocks any add/open. The gate is MU's blowout fiscal Q3 (+17% rev/+22% op-income, $27B capex, 16 SCAs ~$100B contracted through 2030). This is the cleanest confirmation yet that the AI-memory/hyperscaler-capex flow is structurally intact — so the disciplined move is to HOLD the compute franchises through their rate-driven score drift (NVDA/ASML/AVGO), not reflexively trim them; I'd add MU if stale_policy allowed, but it doesn't. The only genuinely new negative flow signals are in energy, where the pillar sits at 34.55% (near the 40% cap): OPEC+'s fifth straight 188k bpd Aug hike with Hormuz recovering erodes the inflation-hedge premium, and MP's China MOFCOM No.23 blacklist directly pressures its magnet-ramp thesis. I trim two decisively — MP -2pp (blacklist + unconfirmed FCF inflection + drift overweight, DoD floor keeps a base slot) and GEV -2pp (pure-drift overweight 4.74%->8.93%, ~21% June valuation surge, score drift to 63 near break). Both trims raise cash to 17.78%, above the 15% base ceiling but inside the 25% escalated ceiling (extension escalator active — cited). CCJ/SCCO/NEM held as intact commodity tail-hedges. Book stays at 17 (the 18-20 gap can only close at a full deep with opens unlocked).

Reflection

MU blowout re-confirms AI-memory/hyperscaler-capex flow is structurally intact — hold compute through rate-drift; trim energy overextension (MP China-blacklist, GEV valuation) as OPEC erodes the hedge

Sixth straight patch where a trigger tempts a compute move; MU's $100B SCA book keeps answering the same question — the drift is discount-rate, not demand. What's new this run: I'm finally making a decisive energy sizing call instead of the 2pp-at-a-time nibbling I criticized myself for. MP is the genuine thesis-pressure name (China blacklist bites the magnet ramp, not just multiple) — that's a real flow degradation, not noise. GEV I'm trimming purely on drift/valuation discipline, thesis fully intact. Cash at 17.78% is elevated because scope-lock + stale_policy leave trims with nowhere to red

Positions (17)

• MUMicron Technologycompute

  hold3.78%79
  flow acceleratingconf

  Funder

  Q3 blowout +17% rev/+22% op-income; 16 Strategic Customer Agreements ~$100B contracted through 2030 (20% DRAM, 1/3 NAND) plus $27B capex step-up; rides the ~$725B 2026 hyperscaler capex line as the named HBM3E/HBM4 beneficiary. stale_policy blocks the add the print would otherwise justify.

  Unwind

  HBM bookings falling below the 15% entry trigger, a memory ASP roll-over signalling the cycle breaking, or the SCA book failing to convert to shipped revenue.

  Catalyst

  Next Micron quarterly print + HBM4 qualification updates from hyperscaler customers.

• TSMTaiwan Semiconductor Manufacturingcompute

  hold6.55%83
  flow steadyconf

  Funder

  Leading-edge foundry monopoly (<3nm), >50% GM, prodigious FCF; Goldman's $920B-$1.4T 2027 AI-capex forecast names TSMC explicitly, CHIPS $6.6B Arizona disbursement locked. MU's blowout flows straight through TSMC capacity.

  Unwind

  Intel 18A closing within one node on verified yield (exit invalidation), or a foundry-price/CHIPS reversal breaking the margin structure.

  Catalyst

  July Q2 TSMC report (flagged 'most important' to calm chip nerves); Intel 18A yield reports.

• NVDANVIDIAcompute

  hold3.10%72
  flow softeningconf

  Funder

  CUDA/accelerator moat, ~75% GM, fortress balance sheet; ~$725B 2026 hyperscaler capex anchored on Blackwell/Rubin (MSFT/AMZN/GOOGL/META). Already right-sized from 8.84% to 3.10% on ASIC-competition drift.

  Unwind

  Two consecutive quarters of data-center revenue deceleration, or ASIC share (Marvell/Broadcom custom silicon) demonstrably taking training-compute TAM.

  Catalyst

  Q3 gross-margin guidance; hyperscaler custom-silicon award cadence.

• ASMLASML Holdingcompute

  hold3.11%63
  flow softeningconf

  Funder

  EUV lithography monopoly — the single most irreplaceable advanced-semis tool, ~50% GM, multi-year backlog; Norway GPFG holds, Coatue/Third Point added Q1; TSMC/Samsung/SMIC 2025-27 EUV orderbook backstops cash. MU's HBM ramp pulls memory-fab EUV demand.

  Unwind

  A July-earnings bookings miss confirming a genuine litho-order break (not multiple compression), or tightened export controls cutting the China orderbook.

  Catalyst

  July ASML earnings + bookings.

• AVGOBroadcomcompute

  hold2.40%62
  flow softeningconf

  Funder

  Custom-silicon ASIC leader (~70% share) + VMware software, huge FCF, $7B+ buyback; GOOG TPU multi-gen, META MTIA, Anthropic 3.5GW ASIC contracts; Q2 AI segment +143% to $10.8B, $30B+ bookings. Already trimmed to 2.40%.

  Unwind

  Custom-chip revenue guidance missing the $25B run-rate floor, or hyperscaler ASIC award losses.

  Catalyst

  Next Broadcom AI-revenue guide.

• ANETArista Networkscompute

  hold2.06%67
  flow steadyconf

  Funder

  Durable hyperscaler-networking franchise, ~65% GM, net cash, single-image EOS software moat, Ullal capital discipline; Microsoft & Meta named largest customers funding ~35% YoY growth; Morgan Stanley PT $180->$190. Lock 4d, unlock=none — hold regardless.

  Unwind

  MSFT/Meta concentration break, Spectrum-X (NVDA) Ethernet displacement, or forward P/E >45x with decelerating growth.

  Catalyst

  Q2 sequential growth vs prior 8.9%.

• FNcompute

  hold1.46%63
  flow softeningconf

  Funder

  Fabrinet — capital-light, debt-free optical transceiver/packaging interconnecting hyperscaler AI clusters; AWS dominant customer drove ~35.9% YoY; 800G/1.6T demand from NVDA/AMD clusters. Q3 beat ($3.72 vs $3.56). Already trimmed to floor; further trim would dust-close.

  Unwind

  Datacom segment YoY growth falling below 25%, or P/E >35x while growth slows (valuation invalidation).

  Catalyst

  Next earnings guidance on 800G transceiver demand sustainability.

• CCJCamecoenergy

  hold7.02%65
  flow steadyconf

  Funder

  Tier-1 Saskatchewan uranium + Westinghouse 49% JV with Brookfield; utility contract book $60+/lb vs term ~$93/lb; Kazatomprom 8Mlb cut sustains deficit; DOE $17.5B AP1000 loan commitment (Jun 25) and AI-DC nuclear demand. Commodity tail-hedge slot.

  Unwind

  Uranium term price rolling under contract-book economics, a Westinghouse JV impairment, or Kazatomprom flooding supply.

  Catalyst

  Uranium term-market prints; DOE nuclear loan disbursements.

• GEVGE Vernovaenergy

  trim6.48%-2.00pp63
  flow acceleratingconf

  Funder

  Gas-turbine + grid franchise, ~$163B backlog (growing to ~$200B by 2027), 100GW turbine backlog, 10-20% price realization; Norway GPFG added post-spin; Oracle $90-95B FY27 + Alphabet $80B capex pull-through. Thesis intact — trimming the pure-drift overweight (4.74%->8.93%) and the ~21% June valuation surge back toward intent, score drift -12 to 63 near the break line.

  Unwind

  Backlog conversion stalling, margin realization missing the 5%->20%+ ROA path, or EV/EBITDA breaching the 25x exit ceiling.

  Catalyst

  Backlog update + Q2 margin realization print.

• SCCOSouthern Copperenergy

  hold6.50%63
  flow steadyconf

  Funder

  Lowest-cost copper producer, vast reserves, fat margins, large dividend; copper supply deficit ~320k tonnes 2026, record Q1 NI $1.58B; AI/data-center ~30% of new copper demand by 2030 (BloombergNEF). Commodity tail-hedge slot — insulated from the OPEC oil headwind.

  Unwind

  Copper falling back under the $5/lb entry trigger, a Peru/Mexico permitting reversal, or the deficit thesis breaking.

  Catalyst

  Copper spot + BHP/peer copper margin prints.

• MPMP Materialsenergy

  trim3.87%-2.00pp
  flow reversingconf

  Funder

  Only scaled US rare-earth + magnet producer; DoD $400M Series A preferred + $150M loan + 10-yr $110/kg NdPr price floor + 10-yr magnet offtake for the 10X facility. BUT China MOFCOM No.23 blacklist (Jun 22) now threatens processing-tech access and the FCF-positive magnet-ramp entry trigger is unconfirmed. Trimming the drift overweight (4.03%->6.14%) on worsened geopolitical/execution overhang; DoD

  Unwind

  Blacklist blocking the 10X magnet-facility construction, FCF-positive inflection failing to confirm, or the DoD price-floor/offtake being repealed.

  Catalyst

  10X magnet-facility construction milestones; further MOFCOM escalation.

• NEMNewmont Corporationenergy

  hold4.69%89
  flow softeningconf

  Funder

  Largest gold producer, tier-1 long-life assets, strong post-Newcrest FCF/dividend, Red Chris $500M federal funding; central-bank gold accumulation. Score 89 (highest in energy). Held as a required tail-risk equity hedge against a frozen-Fed stagflation re-acceleration — the exact scenario the anchor role exists for; lock 9d, unlock=none.

  Unwind

  Gold breaking durably below key support with real yields structurally rising on Fed credibility (not stagflation), invalidating the safe-haven bid, plus FCF/cost deterioration.

  Catalyst

  CPI/PCE prints; central-bank gold-purchase disclosures.

• KTOSKratos Defensedefense

  hold10.01%
  flow steadyconf

  Funder

  Tactical drones (XQ-58 Valkyrie), hypersonics, turbine engines — DAWG-adjacent; DoD MACH-TB 2.0 $1.45B IDIQ, Project Helios $68.3M, USMC Valkyrie mods; ARK accumulation + UK £5B drone program. Out of scope this patch — held at delta 0.

  Unwind

  Revenue-scale/margin-firming inflection failing to confirm, or DAWG/drone procurement lines being cut in NDAA markup.

  Catalyst

  NDAA markup; quarterly contract-flow print.

• HEIHEICOdefense

  hold12.00%68
  flow steadyconf

  Funder

  Defense/aero aftermarket compounder — Mendelson family owners since 1957, 20%+ FCF CAGR, disciplined serial acquirer ($1B+/yr); Q2 FSG/ETG beats, NDAA mandatory funding + commercial aerospace MRO. Out of scope this patch — held at delta 0.

  Unwind

  Forward P/E sustained >54x with organic growth falling below the 6% floor, or a value-destructive acquisition turn.

  Catalyst

  Next Q earnings; organic-growth trajectory vs 6% floor.

• PSNdefense

  hold2.52%50
  flow softeningconf

  Funder

  C5ISR/cyber government-services prime; MDA SHIELD $151B-ceiling IDIQ, DTRA cyber $137M, USAF MATOC $15B, Navy WEXMAC $10B; $1.1-1.4B Blatnik Bridge win. Out of scope this patch — held at delta 0 (score 50, watch closely at next deep).

  Unwind

  Book-to-bill failing to confirm, MDA SHIELD task-order conversions not materialising, or further confidential-contract softness.

  Catalyst

  Next earnings book-to-bill; SHIELD task-order awards.

• LLYEli Lillybiology

  hold2.50%70
  flow steadyconf

  Funder

  Premier pharma compounder — Mounjaro/Zepbound GLP-1 + retatrutide Ph3 extends a multi-decade runway, deep margins; Norway GPFG and large AM holders; EMA Jaypirca CLL opinion. Out of scope this patch — held at delta 0; lock 16d.

  Unwind

  Tirzepatide US share loss >10pts, an oral-GLP-1 disruption, or P/E overstretch with pipeline stall.

  Catalyst

  GLP-1 competitive-pricing signals; retatrutide readouts.

• VRTXVertex Pharmaceuticalsbiology

  hold2.18%76
  flow steadyconf

  Funder

  CF monopoly (Trikafta) cash engine, self-funded, ~87% GM; Casgevy pediatric FDA approval (ages 2+, 53-day expedited, 100% primary endpoint) + suzetrigine non-opioid pain optionality; GPFG/large AM holders. Out of scope this patch — held at delta 0; lock 16d.

  Unwind

  CF franchise erosion, a suzetrigine launch failure, or a Casgevy commercialization stall.

  Catalyst

  Suzetrigine (Journavx) launch traction; CRISPR partnership revenue splits.

Warnings

• §2 cap re-applied after pillar tilt: HEI
• §5.4 cash escalator: cash_pct 17.78% above base band top 15% allowed (active: extension, ceiling 25%)
• §5.4 cash escalator: cash 19.77% above neutral base band top 15% allowed (active: extension, ceiling 25%)
• position_count: 17 < 18 after mechanical closes (§2 floor) — book under-populated; strategist must open replacements next run
• ledger stale (ledger over-bought (cash -37.02% of NAV)) — rebalance diffed against intent

Conviction-lock actions

1. Turn 1ConvictionGuard (§6.5d)

   —
2. Turn 2ConvictionGuard (§6.5d)

   —

Cost breakdown

Per-call cost computed from cost.js pricing constants (Opus 4.7, Sonnet 4.6, Haiku 4.5). Cache-read tokens billed at 10% of input. See Cost & ROI for the rolling 30-day ledger.